Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

BMS-754807 (IGR-IR/IR Inhibitor)

Tablets, Oral, 100mg, Once daily, Days 1 - 5 and 15 - 17

DRUG

Metformin

Tablets, Oral, (1000mg on Days 3 - 9) and (2000mg on Days 10 - 17), Once daily

Trial Locations (1)

Local Institution, Melbourne